• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Capstone Holding Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    11/24/25 4:10:31 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CAPS alert in real time by email
    false 0000887151 0000887151 2025-11-18 2025-11-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): November 18, 2025

     

    CAPSTONE HOLDING CORP.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-33560   86-0585310
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (I.R.S. Employer
    Identification No.)

     

    5141 W. 122nd Street

    Alsip, IL 60803

    (Address of principal executive offices)

     

    Registrant’s telephone number, including area code: (708) 371-0660

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.0005 per share   CAPS   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders

     

    On November 18, 2025, Capstone Holding Corp. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”) at 5141 W. 122nd Street, Alsip, IL 6080.

     

    As of the close of business on September 24, 2025, the record date for the Annual Meeting (the “Record Date”), 7,291,268 votes outstanding, consisting of (i) 6,306,205 shares of Common Stock and (ii) 985,063 shares of Series B Preferred Stock, each entitled to vote at the Annual Meeting. At the Annual Meeting, a total of 5,452,081 votes, comprised of shares of the Company’s Common Stock and Series B Preferred Stock, equivalent to approximately 74.78% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The holders of Series B Preferred Stock were not entitled to vote on Proposal Seven. The matters that were voted upon at the Annual Meeting, and the number of votes cast for or against/withheld, as well as the number of abstentions and broker non-votes, as to such matters, where applicable, are set forth below.

     

    1. The two nominees for Class I director were elected to serve a one-year term as follows:

     

    Director  Votes For   % Votes For   Votes Withheld   % Votes Withheld 
    Fredric J. Feldman, Ph.D.   4,947,466    99.24%    37,900    0.76% 
    Elwood D. Howse, Jr.   4,947,411    99.24%    37,955    0.76% 

     

    2. The proposal to ratify the appointment of GBQ Partners LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained
    5,425,633  16,618  0  9,830

     

    3. The proposal of the change in the state of incorporation of the Company from Delaware to Nevada was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained
    4,967,536  13,840  466,715  3,990

     

    A copy of the forms of the Agreement and Plan of Merger, the articles of incorporation, and the bylaws, respectively, of a company to be incorporated in Nevada for the purpose of the Company merging into it and becoming its wholly owned subsidiary, are attached hereto as Exhibits 2.1, 3.1, and 3.2, respectively, and are incorporated by reference herein. 

     

    4. The proposal to adopt Capstone Holding Corp. 2025 Stock Incentive Plan was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained
    4,927,449  54,617  466,715  3,300

     

    A copy of the Capstone Holding Corp. 2025 Stock Incentive Plan is attached hereto as Exhibit 10.1 and is incorporated by reference herein.

     

    1

     

     

    5. The proposal, in a non-binding advisory vote, of the compensation of the Company’s named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the SEC was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained
    4,939,083  43,380  466,715  2,903

     

    6. The proposal to select the frequency of holding the stockholder advisory vote on the Company’s executive compensation once every three years was approved as follows:

     

    Every Year  Once Every Two Years  Once Every Three Years  Votes Abstained
    360,822  108  4,617,648  6,788

     

    7. The proposal to approve possible future payments to Nectarine Management LLC was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained  Votes Uncast
    474,102  52,660  466,715  6,018  4,452,586

     

    8. The proposal of the adjournment of the Annual Meeting was approved as follows:

     

    Votes For  Votes Against  Broker Non-Votes  Votes Abstained
    4,914,463  47,794  466,715  23,109

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit
    Number
      Exhibits
    2.1   Form of the Agreement and Plan of Merger 
    3.1   Form of Articles of Incorporation
    3.2   Form of Bylaws
    10.1   Capstone Holding Corp. 2025 Stock Incentive Plan
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 24, 2025 Capstone Holding Corp.
         
      By: /s/ Matthew E. Lipman
      Name:  Matthew E. Lipman
      Title: Chief Executive Officer

     

    3

     

    Get the next $CAPS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAPS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CAPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Schultz Edward Christopher

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/22/25 3:55:58 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Lipman Matthew E. claimed ownership of 2,650,436 shares (SEC Form 3)

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/22/25 3:53:49 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Holliman John M Iii claimed ownership of 1,095 shares (SEC Form 3)

    3 - Capstone Holding Corp. (0000887151) (Issuer)

    4/14/25 7:04:52 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CAPS
    SEC Filings

    View All

    Capstone Holding Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    12/15/25 7:30:43 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    12/2/25 8:20:42 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    11/28/25 3:10:47 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care